The European Commission, the UK Competition and Markets Authority and the courts, are re-writing the rules on the interaction between patent settlements and pharmaceutical life cycle management. Our webinar will provide an update and guidance on what is and is not permissible. Whilst focusing on pharmaceutical cases, we will explain how these same types of patent settlement issues are also relevant to other industries within the technology sector
This webinar series will be particularly relevant to professionals working in the life sciences and pharmaceutical sector and/or with exposure to competition law issues including:
- General Counsel, heads of legal and senior in-house lawyers;
- Specialist in-house competition lawyers; and
- Corporate governance specialists and commercial managers who encounter competition law issues in their work
This webinar will be led by John Schmidt, a partner in our Regulation and Markets Group with extensive experience in dealing with competition authorities at both national and EU level. He will be joined by his colleague Marianne Charrier, a solicitor who specialises in competition law and John MacKenzie, a partner in our Commercial Dispute Resolution Group who specialises in intellectual property and IT matters, who will also speak about the application of patent settlement issues in industries beyond pharmaceuticals.